chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Basophil count decreased, Basophil percentage decreased, Blood calcium normal, Blood chloride decreased, Blood creatinine normal
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Blood culture, Blood glucose normal, Blood lactic acid normal, Blood magnesium normal, Blood phosphorus decreased
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea normal, Carbon dioxide normal, Chills
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Eosinophil count decreased, Eosinophil percentage decreased, Glomerular filtration rate, Haematocrit normal, Haemoglobin normal
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Headache, Injection site rash, International normalised ratio normal, Lymphocyte count decreased, Lymphocyte percentage decreased
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Malaise, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume increased
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Monocyte count decreased, Monocyte percentage, Nausea, Neck pain, Neutrophil count increased
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Neutrophil percentage increased, Pain, Photophobia, Platelet count normal, Polymerase chain reaction
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Prothrombin time prolonged, Pyrexia, Red blood cell count normal, Red cell distribution width normal, Scab
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Secretion discharge, Skin lesion, Staphylococcus test, White blood cell count increased
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Back pain, Blood chloride decreased, Blood culture negative, Blood phosphorus decreased, Chills
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Headache, Injection site rash, Lymphocyte count decreased, Lymphocyte percentage decreased, Malaise
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Mean platelet volume increased, Nausea, Neck pain, Neutrophil count increased, Neutrophil percentage increased
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Pain, Photophobia, Progressive vaccinia, Pyrexia, Scab
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, JEV1, SMALL, ANTH, HEPAB, JEV1
Symptoms: Secretion discharge, Skin lesion, Staphylococcus test negative
Clinical narrative: The following information was downloaded from VAERS webpage on 21 Nov 2016 (available as of 16 Nov 2016). A 19 year old healthy male received a dose of IXIARO (batch number JEV15D92E) on 04 Aug 2016. Co-suspect vaccination included TWINRIX I.M., and BIOTHRAX I.M.  on the same day; as well as ACAM2000 I.D. into the  left arm on 05 Aug 2016. He had received a new tattoo on his left upper arm on 04-AUG 2016.  On 11 Aug 2016 the vaccinee felt ill; on 12 Aug 2016 he woke up with a rash over his new tattoo site. He developed fever, chills, nausea, headache with photophobia (severity described as 3/10; intermittent throbbing pain across forehead; 'mostly associated with fever'), lower back pain (dull pain in the middle of his lower back), and neck / neck flexion pain (associated with fever). On 12 Aug 2016 he was hospitalised for vaccinia spread into recent tattoo, for four days. For treatment he received IV fluids, TYLENOL and Ibuprofen, and improved significantly within 24 hours of admission  -  with ongoing lesions within tattoo and additional lesions on abdomen and chest. Haematology  [most likely of 12 Aug 2016] was without significantly abnormal values, including  blood culture and staph test, except for mean platelet volume 10.6 fL (increased), neutrophils 84.8%  (8.83 x 1000/microL, increased), lymphocytes 8.0 % (0.8 x 1000/microL, decreased), chloride 95 mmol/L (decreased), and phosphate 2.1 mg/dL (decreased). [Please note that additional lab values were considered abnormal as per VAERS, however, not so as per reporter.] During hospitalisation,  existing lesions erupted, drained and crusted. He had not recovered by time of report to VAERS.
Age: 66.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous report was received from a nurse and refers to a 66 year old male patient with no drug reactions or allergies. The patient had no pertinent medical history. On 17-OCT-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 into arm (dose, lot number and expiration date were not reported). Concomitant therapies included CRESTOR, metformin and lisinopril (manufacturer unknown). On 17-OCT-2016, the patient had a strong reaction to the vaccine, including redness and pain at the upper arm injection site. The patient notified the physician, who prescribed TYLENOL (dose and frequency were unknown) and warm compresses to affected area (duration and frequency were unknown). The patient did not seek medical attention. On an unspecified date in 2016 (reported as "a couple of days later"), the patient's symptoms were resolved. The relationship between PNEUMOVAX 23 and the events was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: This spontaneous report was received from a nurse and refers to a 66 year old male patient with no drug reactions or allergies. The patient had no pertinent medical history. On 17-OCT-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 into arm (dose, lot number and expiration date were not reported). Concomitant therapies included CRESTOR, metformin and lisinopril (manufacturer unknown). On 17-OCT-2016, the patient had a strong reaction to the vaccine, including redness and pain at the upper arm injection site. The patient notified the physician, who prescribed TYLENOL (dose and frequency were unknown) and warm compresses to affected area (duration and frequency were unknown). The patient did not seek medical attention. On an unspecified date in 2016 (reported as "a couple of days later"), the patient's symptoms were resolved. The relationship between PNEUMOVAX 23 and the events was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Chapped lips, Injection site erythema, Lip exfoliation, Lip swelling, Oral discomfort
Clinical narrative: This spontaneous report was received from a registered nurse refers to a 21 year old female patient. The patient no pertinent medical history or concomitant medications. She was allergic to DAYTRANA. On 08-NOV-2016, the patient was vaccinated with a second dose of GARDASIL 9 (lot# and expiry date not reported) intramuscular. On the same day, the patient developed "redness in her right arm from her elbow area up to her shoulder" and her lip began to swell. The next morning, on 09-NOV-2016, the swelling went down on her lip and the redness on her arm disappeared, but her lips were chapped and she felt a burning sensation inside her mouth in the lower jaw area. The patient was given unspecified treatment for the events. At the time of the report the outcome of chapped lips and "burning sensation inside her mouth" was reported as not recovered. The reporter did not provide the relatedness of the events with GARDASIL 9. No product quality complaint was involved. Additional information has been requested.
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Chapped lips, Erythema, Lip swelling, Oral discomfort
Clinical narrative: This spontaneous report was received from a registered nurse refers to a 21 year old female patient. The patient no pertinent medical history or concomitant medications. She was allergic to DAYTRANA. On 08-NOV-2016, the patient was vaccinated with a second dose of GARDASIL 9 (lot# and expiry date not reported) intramuscular. On the same day, the patient developed "redness in her right arm from her elbow area up to her shoulder" and her lip began to swell. The next morning, on 09-NOV-2016, the swelling went down on her lip and the redness on her arm disappeared, but her lips were chapped and she felt a burning sensation inside her mouth in the lower jaw area. The patient was given unspecified treatment for the events. At the time of the report the outcome of chapped lips and "burning sensation inside her mouth" was reported as not recovered. The reporter did not provide the relatedness of the events with GARDASIL 9. No product quality complaint was involved. Additional information has been requested.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU3, PNC13
Symptoms: Chills, Injection site swelling, Tachycardia
Clinical narrative: Patient referred several symptoms after receiving flu/pneumonia vaccine. She presented muscular pain, fever, chills, heartbeat, tachycardia, soreness, redness, swelling where the shot was administered.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU3, PNC13
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site swelling, Myalgia
Clinical narrative: Patient referred several symptoms after receiving flu/pneumonia vaccine. She presented muscular pain, fever, chills, heartbeat, tachycardia, soreness, redness, swelling where the shot was administered.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU3, PNC13
Symptoms: Pyrexia, Tachycardia
Clinical narrative: Patient referred several symptoms after receiving flu/pneumonia vaccine. She presented muscular pain, fever, chills, heartbeat, tachycardia, soreness, redness, swelling where the shot was administered.
Age: 54.0
Sex: F
Vaccine: FLUC4, FLUX
Symptoms: Eye swelling
Clinical narrative: When I woke that morning I noticed underneath my left eye was swelling, in the corner between my eye and nose a bump about the size of a grape rose on my face.That has went down but is now dark spot and scaley. Still have swelling and it has been almost 3 weeks since shot.
Age: 54.0
Sex: F
Vaccine: FLUC4, FLUX
Symptoms: Eyelid exfoliation, Eyelid oedema, Skin discolouration
Clinical narrative: When I woke that morning I noticed underneath my left eye was swelling, in the corner between my eye and nose a bump about the size of a grape rose on my face.That has went down but is now dark spot and scaley. Still have swelling and it has been almost 3 weeks since shot.
Age: 19.0
Sex: M
Vaccine: MENB, MEN
Symptoms: Chills, Headache, Injection site pain, Pyrexia, Swelling
Clinical narrative: Chills, palpitations, severe headache.  Tachycardia up to 130 and bigeminy.Tmax 102.2.
Age: 19.0
Sex: M
Vaccine: MENB, MEN
Symptoms: Blood test, Body temperature increased, Chest X-ray, Chills, Electrocardiogram
Clinical narrative: Chills, palpitations, severe headache.  Tachycardia up to 130 and bigeminy.Tmax 102.2.
Age: 19.0
Sex: M
Vaccine: MENB, MEN
Symptoms: Extrasystoles, Headache, Palpitations, Tachycardia, Urine analysis
Clinical narrative: Chills, palpitations, severe headache.  Tachycardia up to 130 and bigeminy.Tmax 102.2.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Dizziness, Nausea
Clinical narrative: Dizziness and nausea.
Age: 13.0
Sex: F
Vaccine: HPVX
Symptoms: Abdominal pain upper, Diarrhoea, Headache, Nausea
Clinical narrative: Severe Stomach Pains, Nausea, Diarhea and headache.
Age: 71.0
Sex: F
Vaccine: IPV, YF
Symptoms: Computerised tomogram head normal, Hypoaesthesia, Spinal X-ray normal
Clinical narrative: On 10/29 she presented to an outside facility with c/o left hand and left foot numbness. No weakness or pain. Sensation persisted throughout the day, waxing and waning in severity. Presented to her local ED. No other focal symptoms. Had started a new exercise routine for her back the day prior. Per outside records, exam was unremarkable. She was admitted overnight for stroke work up.  CT of brain was read as normal. EKG normal. CT of the spine showed multi-level disc disease mostly in C-spine. MRI head negative for stroke. Diagnosis by outside hospital was that her sx were due to her spinal DJD. Of note she also received IPV the same day as yellow fever. Reason for yellow fever vaccine was that she is going abroad for a year to work in an orphanage. Risks/benefits of yellow fever vaccination at her age were discussed at length prior to administration of vaccine.
Age: 72.0
Sex: M
Vaccine: FLUX
Symptoms: Fatigue, Insomnia, Myalgia
Clinical narrative: Muscle Aches; Insomnia ; Excessive Tiredness.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Migraine, Pain, Rhinorrhoea, Vomiting
Clinical narrative: Initial unsolicited report received from a consumer on 15-Nov-2016. This case involves a 65-year old female patient who was vaccinated with first dose of FLUZONE HD (Batch number, expiry date, dose, route, dose in series were not reported) in left deltoid on an unknown date. Patient's pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) includes Soy, Formaldehyde, Pcn, Wheat, Corn , Allergies to 70 items. It was also reported that patient had no illness at the time of vaccination. Concomitant medications was not reported. It was also reported that any other vaccinations within four weeks of vaccinations was none. On an unknown date, within 15-minute following the vaccination, patient began vomiting profusely but went to home. Since then patient had migraines, runny nose, and body aches cough with wheezing. Patient required emergency room (ER)/ doctor visit. Laboratory investigations were not reported. Patient did not required corrective treatment. The outcome of event was reported as not recovered. List of documents held by sender: none.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Wheezing
Clinical narrative: Initial unsolicited report received from a consumer on 15-Nov-2016. This case involves a 65-year old female patient who was vaccinated with first dose of FLUZONE HD (Batch number, expiry date, dose, route, dose in series were not reported) in left deltoid on an unknown date. Patient's pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) includes Soy, Formaldehyde, Pcn, Wheat, Corn , Allergies to 70 items. It was also reported that patient had no illness at the time of vaccination. Concomitant medications was not reported. It was also reported that any other vaccinations within four weeks of vaccinations was none. On an unknown date, within 15-minute following the vaccination, patient began vomiting profusely but went to home. Since then patient had migraines, runny nose, and body aches cough with wheezing. Patient required emergency room (ER)/ doctor visit. Laboratory investigations were not reported. Patient did not required corrective treatment. The outcome of event was reported as not recovered. List of documents held by sender: none.
Age: 72.0
Sex: F
Vaccine: FLUX
Symptoms: Pain
Clinical narrative: Initial unsolicited report received from a pharmaciston 15 November 2016. This case involves a 72-year-old female patient who was vaccinated with INFLUENZA VACCINE (Flu vaccine) intramuscularly       (batch number, expiry date of the product, dose, dose in series and site of administration were not reported) on an unspecified date (reported as 'last year'). Illness at the time of vaccination was reported as none. The reporter was unaware that she had any other symptoms at the time of administration. The patient did not receive any other vaccinations within four weeks of vaccinations noted above. No further information regarding concomitant medications was reported. On an unspecified date and duration following the vaccination, the patient suffered from pain. Relevant laboratory data was reported as none. Corrective treatment was unknown. The outcome of the event was not recovered. List of documents held by sender: none.
Sex: F
Vaccine: FLUX
Symptoms: Food allergy, Hypersensitivity
Clinical narrative: Initial unsolicited report received from a consumer (patient) via other company (Merck) (Case Number: 00262710) on 16 Nov 2016. This case involves a female patient (age not reported) who was vaccinated with a dose of INFLUENZA VACCINE (Batch number, expiry date, dose, route and site of administration was not reported) on an unknown date. The patient medical history and concomitant medications were not reported. On an unknown date after receiving the vaccine the patient had an unspecified allergic reaction to the egg content. The patient lab tests and correcctive treatment was not reported. The outcome of the event was not reported. List of documents held by sender: none.
Sex: M
Vaccine: TD
Symptoms: Allergy to vaccine, Syncope
Clinical narrative: Initial unsolicited report received from a healthcare professional via other company (Pfizer) (Manufacturer Report Number: 2016505985) on 16-Nov-2016. This case involves a male patient (onset age not reported) who was vaccinated with a dose of Tetanus-Diphtheria Toxoids Td (batch number, expiration date, dose, dose in series, route and site of administration were not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, unspecified timeframe following vaccination the patient experienced allergy to vaccine (allergy to tetanus vaccine) and sign reported as syncope. Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
Age: 52.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Seizure
Clinical narrative: Initial unsolicited report received from a physician on 16 November 2016. This case is linked with 2016SA210933. This case involves 53-years-old male patient who was vaccinated with a dose of FLUZONE QIV (Batch number, expiry date, dose, dose number and site of administration was not reported) via intramuscularly on an unspecified date. Patient had no medical history of seizures. Concomitant medications were not reported. On 16 November 2016, few hours following vaccination patient experienced seizure. Lab data and corrective treatment were not reported. The outcome of event was not reported. Upon internal review, the company decided to consider the event serious because of important medical event :seizure. List of documents held by sender: none. Sender's Comments: Seizure is listed with INFLUENZA QUADRIVAL A-B VACCINE. Time to onset is compatible with the role of the vaccine. Further information on the patient's previous immunization history, concurrent conditions, detailed medical history and lab data to confirm alternative etiology/diagnosis etc. will be needed to completely assess this case. Based on the available information, a role of the vaccine cannot be ruled out.
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Seizure
Clinical narrative: Initial unsolicited report received from a physician on 16 Nov 2016. This case was linked with 2016SA210925 (same vaccine and reporter). This case involves a male patient (age not reported) who was vaccinated with a dose of FLUZONE QIV (Batch number, expiry date, dose, route and site of administration was not reported) on an unknown date. The patient medical history was not reported. The patient concomitant medications were not reported. On an unknown date, few hours after vaccination the patient had seizure. The patient lab tests and corrective treatment was not reported. The outcome of the event was unknown. Upon internal review the case was considered as serious because of important medical event seizure. List of documents held by sender: none. Sender's Comments: Seizure is listed with INFLUENZA QUADRIVAL A-B VACCINE. However, further information on the latency, patient's previous immunization history, concurrent conditions, detailed medical history and lab data to confirm alternative etiology/diagnosis etc. will be needed to completely assess this case. Based on the available information, a role of the vaccine cannot be ruled out.
Age: 17.0
Sex: M
Vaccine: HPV9
Symptoms: Anaphylactic reaction, Urticaria
Clinical narrative: Hives which then progressed to anaphylaxis. Was seen in ER given epinephrine and steroids. Next day, symptoms recurred and he returned to ER and received epi and steroids again.
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Pain, X-ray limb
Clinical narrative: upper arm left shoulder pain, raising arm with moderate to severe pain. Unjection?
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Burning sensation, Chills, Disorientation, Dyspnoea
Clinical narrative: After shot was administered into my left arm, I felt a burning sensation and I started having problems walking on my right leg. Two days later, I had a severe headache followed by fever, chills, breathlessness, weakness and disorientation.
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Pyrexia
Clinical narrative: After shot was administered into my left arm, I felt a burning sensation and I started having problems walking on my right leg. Two days later, I had a severe headache followed by fever, chills, breathlessness, weakness and disorientation.
Age: 48.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Injection site pain
Clinical narrative: Patient states administration hurt badly and now has decreased range of motion and pain/numbness to fingers.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU4
Symptoms: Body temperature decreased, Chest X-ray normal, Cough, Fatigue, Productive cough
Clinical narrative: STARTED WITH RUNNY NOSE, COUGH WITH PHLEGM WHICH WAS YELLOW IN COLOR. BY 2 DAYS LATER, CONT. WITH FATIGUE, FEVER OF 101.6, THEN DOWN TO 92.4 F AFTER TAKING EX STRENGTH TYLENOL. WENT TO ER ON 11/17/16, HOSPITALIZED FOR 5 DAYS.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU4
Symptoms: Pyrexia, Rhinorrhoea, Sputum discoloured
Clinical narrative: STARTED WITH RUNNY NOSE, COUGH WITH PHLEGM WHICH WAS YELLOW IN COLOR. BY 2 DAYS LATER, CONT. WITH FATIGUE, FEVER OF 101.6, THEN DOWN TO 92.4 F AFTER TAKING EX STRENGTH TYLENOL. WENT TO ER ON 11/17/16, HOSPITALIZED FOR 5 DAYS.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU4
Symptoms: Activities of daily living impaired, Blood test, Chest X-ray, Chills, Cough
Clinical narrative: STARTED WITH RUNNY NOSE, COUGH WITH PHLEGM WHICH WAS YELLOW IN COLOR. BY 2 DAYS LATER, CONT. WITH FATIGUE, FEVER OF 101.6, THEN DOWN TO 92.4 F AFTER TAKING EX STRENGTH TYLENOL. WENT TO ER ON 11/17/16, HOSPITALIZED FOR 5 DAYS.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU4
Symptoms: Dizziness, Fatigue, Headache, Injection site pain, Insomnia
Clinical narrative: STARTED WITH RUNNY NOSE, COUGH WITH PHLEGM WHICH WAS YELLOW IN COLOR. BY 2 DAYS LATER, CONT. WITH FATIGUE, FEVER OF 101.6, THEN DOWN TO 92.4 F AFTER TAKING EX STRENGTH TYLENOL. WENT TO ER ON 11/17/16, HOSPITALIZED FOR 5 DAYS.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU4
Symptoms: Laboratory test, Myalgia, Oropharyngeal pain, Oxygen saturation abnormal, Productive cough
Clinical narrative: STARTED WITH RUNNY NOSE, COUGH WITH PHLEGM WHICH WAS YELLOW IN COLOR. BY 2 DAYS LATER, CONT. WITH FATIGUE, FEVER OF 101.6, THEN DOWN TO 92.4 F AFTER TAKING EX STRENGTH TYLENOL. WENT TO ER ON 11/17/16, HOSPITALIZED FOR 5 DAYS.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU4
Symptoms: Pyrexia, Rhinorrhoea, Skin discolouration, Sneezing, Sputum discoloured
Clinical narrative: STARTED WITH RUNNY NOSE, COUGH WITH PHLEGM WHICH WAS YELLOW IN COLOR. BY 2 DAYS LATER, CONT. WITH FATIGUE, FEVER OF 101.6, THEN DOWN TO 92.4 F AFTER TAKING EX STRENGTH TYLENOL. WENT TO ER ON 11/17/16, HOSPITALIZED FOR 5 DAYS.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU4
Symptoms: Swelling, Walking aid user
Clinical narrative: STARTED WITH RUNNY NOSE, COUGH WITH PHLEGM WHICH WAS YELLOW IN COLOR. BY 2 DAYS LATER, CONT. WITH FATIGUE, FEVER OF 101.6, THEN DOWN TO 92.4 F AFTER TAKING EX STRENGTH TYLENOL. WENT TO ER ON 11/17/16, HOSPITALIZED FOR 5 DAYS.
Age: 53.0
Sex: F
Vaccine: MEA
Symptoms: Erythema, Swelling
Clinical narrative: Swelling, redness.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: C-reactive protein increased, Gait disturbance, Headache, Inflammation, Laboratory test abnormal
Clinical narrative: Polymyalgia, jaw pain, headache, sinusitis, laryngitis, sore throat, inability to ambulate. Treated with Omnicef, Levaquin & prednisone. Evaluated by PCP, ENT, rheumatology. Sx and treatment ongoing as of 11/30/2016.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Laryngitis, Myalgia, Oropharyngeal pain, Pain in jaw, Red blood cell sedimentation rate increased
Clinical narrative: Polymyalgia, jaw pain, headache, sinusitis, laryngitis, sore throat, inability to ambulate. Treated with Omnicef, Levaquin & prednisone. Evaluated by PCP, ENT, rheumatology. Sx and treatment ongoing as of 11/30/2016.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Sinusitis, Viral titre, White blood cell count increased
Clinical narrative: Polymyalgia, jaw pain, headache, sinusitis, laryngitis, sore throat, inability to ambulate. Treated with Omnicef, Levaquin & prednisone. Evaluated by PCP, ENT, rheumatology. Sx and treatment ongoing as of 11/30/2016.